Monitoring for myocarditis during treatment initiation with clozapine.

Sandarsh, Surya; Bishnoi, Ram J; Shashank, Reddy Beesam; Miller, Brian J; Freudenreich, Oliver; McEvoy, Joseph P

Sandarsh, Surya; Bishnoi, Ram J; Shashank, Reddy Beesam; Miller, Brian J; Freudenreich, Oliver; McEvoy, Joseph P.

Afiliación

Sandarsh S; Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Bishnoi RJ; East Central Regional Hospital, Augusta, GA, USA.
Shashank RB; Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Miller BJ; East Central Regional Hospital, Augusta, GA, USA.
Freudenreich O; Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, GA, USA.
McEvoy JP; East Central Regional Hospital, Augusta, GA, USA.

Acta Psychiatr Scand ; 144(2): 194-200, 2021 08.

Article en En | MEDLINE | ID: mdl-33997951

Asunto(s)

Antipsicóticos; Clozapina; Miocarditis; Antipsicóticos/efectos adversos; Clozapina/efectos adversos; Humanos; Miocarditis/inducido químicamente; Miocarditis/epidemiología; Estudios Prospectivos; Troponina

Palabras clave

C-reactive protein; clozapine; creatine kinase; eosinophil; myocarditis; troponin I

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antipsicóticos / Clozapina / Miocarditis Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Acta Psychiatr Scand Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google